................................................................................................................. counter
!!! W E L C O M E !!!
In INDIA, people generally relate to stock market as “EASY MONEY” or “SATTA BAZAAR”. For them it’s purely a GAME or matter of sheer LUCK and nothing more than that. But seldom do they know, by following certain PRINCIPLES and taking INFORMED decision, this same platform has the power to take them from rags to riches. No doubt, it has a certain amount of RISK attached to it. But every business or investment has it. What more, the Finance Ministry has already made the long term capital gain as TAX FREE whereas the short term capital gain is taxed at merely 10%. On the economic front, India’s GDP is growing and is expected to grow at scorching pace of more than 8%. Unfortunately, even today our market is being ruled and dominated by FIRANGI’s money. But I can see, the day is not far when our general PUBLIC will change its perception and start putting MOST of their savings in equities as an ** Investment **.
Remember, "K N O W L E D G E" and "P A T I E N C E" are the key to success.
Page copy protected against web site content infringement by Copyscape
AddThis Social Bookmark Button Add to Technorati Favorites Join My Community at MyBloglog! ...<< Top Blogs >>
SAARTHI

Sensex (LIVE- Intraday)

Sensex (LIVE- Intraday)

Friday, October 14, 2005

Jupiter Bioscience- Rs.143.00

Established in 1985, Jupiter Bioscience Limited (JBL) is among the few pharma companies in the world with core competence in peptide chemistry, organic chemistry, chiral chemistry and biotechnology. In fact, JBL was the first company in Asia to introduce and commercialise molecules based on peptide chemistry. It has three specialised product lines viz. Peptide reagents and protected amino acids, Drug intermediates & Speciality Chemicals as well as fine chemicals. JBL has two manufacturing facilities - one at Bidar in Karnataka and the other at Cheriyal in Medak District in Andhra Pradesh, which is a 100% EOU. JBL is very strong not only in research & development but also in process development with its focus on advanced organic and peptide chemistries. It has constantly introduced new peptide reagents, coupling reagents and protected amino acids in the market.

With the successful launch of peptide precursors, the main raw materials for generic peptide drugs, JBL is now globally positioned to manufacture key raw materials for peptide pharmaceuticals in lab scale quantities, pilot scale quantities and commercial quantities. It has developed expertise in peptide precursors in Diagnostics, Vaccines and Peptide Antibiotics apart from concentrating on research of new peptide molecules. JBL is also moving up the value chain to commercialise and introduce generic peptide drugs such as Oxytocin, Vasopressin, Desmopressin, Leuprolide, Lisinopril and Calcitonin in the domestic and international markets. Its thrust has been on Multi-process capabilities of Pharmaceutical intermediates and API's. Lately, it renewed its interest in Speciality Drug Intermediates for treatment of cardiovascular diseases, AIDS and Cancer. To increase it global presence, JBL is aggressively participating in exhibitions, fairs and trade shows all over the world. Moreover, it is presently working on suitable entry strategies into the US and European markets through appropriate alliances. Notably, JBL has following 3 subsidiaries:

Jupiter Bioscience – India which specializes in Manufacturing Drug Intermediates, Specialty Chemicals, Peptide Reagents and Protected Amino Acids.

Sven Genetech – India which specializes in small volume side chain Protected Amino Acids, Peptides, Beta Amino Acids and Unusual Amino Acids. It has established in-house facilities for microbiology and biochemistry to carry out development and scaling up of enzymes and protein purification.

Jupiter Bioscience – USA which offers Custom Peptides from USA and is in process of establishing a facility in USA for offering Clinical and Generic Peptide Bulk Actives.

The year 2005 is a major eventful year wherein patents for a majority of the drugs in the world will expire and open up a huge market for pharmaceutical companies worldwide. JBL is growing steadily year after year with FY05 Sales increasing 7% to Rs.70.50 cr. and the NP growth of 21% to 18.50 cr. For future growth plans, JBL is planning to raise capital through ADR/GDR/FCCB and is also making preferential allotment of 27.50 lakh shares to promoters. Considering these factors, JBL is expected to report Sales of Rs.80 cr. and NP Rs.21 cr. which can lead to on an EPS of Rs.18 on its expanded equity of Rs.11.60 cr. Only aggressive investors are recommended to buy this scrip with a price target of Rs.220 in 6~9 months.

Thursday, October 13, 2005

Flex Foods - Rs.27.50

Incorporated in 1990, Flex Foods Ltd (FFL) is part of the well-known Flex Group. It is in the business of agro based value added food products catering to international markets mainly in Europe, USA, Canada and Middle East. Today, the company is one of the major producers of Freeze-dried & Frozen products in the country. It offers a wide range of Vacuum Freeze Dried, Air-Dried, Frozen and IQF (Individually Quick Frozen) product range of mushrooms, herbs, spices and fruits / vegetables, meeting strict quality & hygiene standards. Canned button mushrooms in various shapes and sizes is also manufactured and sold under the brand name ‘Chef’s Choice’. Recently, the company introduced a new range of frozen and freeze dried culinary herbs for the export market.

FFL can boast of world class manufacturing facilities with state-of-the-art technology, good management practices (GMP) & quality systems. The processing infrastructure includes the most modern plant & equipment from leading technology providers i.e. M/s Niroa’s, Denmark; M/s Non, Holland; M/s Binder, Germany & Eurotex, UK along with others from leading Indian companies. The plant can process upto 20000 MTA of fruits & vegetables per annum in the form of freeze dried, frozen, IQF, air-dried and canned products. The facilities have been certified for Kosher and HACCP standards. In order to achieve the right quality of finished products, most of the input materials including mushroom, herbs and other fruits & vegetables are grown under the supervision of in-house experts making it a fully integrated producer. Besides, a captive mushroom cultivation unit with an annual capacity of 2000 MTA is fully equipped with international quality monitoring techniques and best storage facilities to ensure that the fresh & hygienic inputs are always available to the processing units. Due to the rising demand for frozen food products in international markets, the company has recently expanded and set up a Air dried (Dehydrated) and Frozen (Individually Quick Frozen) facilities for mushrooms, herbs, fruits & vegetables at its existing site at Dehradun at an estimated cost of Rs.28.50 cr.

The Indian mushroom industry is geared for considerable growth in production over the next few years as the export demand escalates. The Middle East, Africa, East European countries etc. are still growing markets for Indian mushrooms and are yet to be tapped. For FY05, company’s net Sales remained flat at Rs.25 cr. but its NP jumped 42% to Rs.8 cr. due to lower tax provision. For FY06 it can report Sales of Rs.30 cr. and NP of Rs.7.50 cr. which means an EPS of Rs.6 on its current equity of Rs.12.44 cr. Investors can accumulate this scrip at declines with a price target of Rs.50 (80% appreciation) in 12~15 months.

Wednesday, October 12, 2005

STOCK WATCH

Kilburn Engineering (Code No: 522101) (Rs.53.55) operates in areas of process design, engineering, manufacture installation and commissioning of turnkey plants and systems catering to petrochemicals, chemical fertilizers, refineries, oil & gas and food processing. To improve its working capital requirement, the company is coming out with 1:1 Rights issue at Rs.25 i.e. 50% discount to its CMP. For FY05 ending 30 Sept 2005, it is expected to report sales of Rs.45 cr. and NP of Rs.6.50 cr. For FY07, it can post NP of Rs.8 cr. on Sales of Rs.70 cr., which means an EPS of Rs.6 on its diluted equity of Rs.13.50 cr. Its share price has the potential to rise 50% and can trade above Rs.60 on ex-right basis. A strong buy as the downside is minimal from current levels
The ongoing panic in the mid cap sector has given a good opportunity to accumulate hotel scrips at reasonable valuations. Sayaji Hotels (Code No: 523710) (Rs.46.35) which touched a high of Rs.73 and has fallen below Rs.50 is one such stock. To cater to the increasing demand for quality rooms, Sayaji is expanding regularly and had constructed and commissioned 44 rooms with state-of-the-art Quorom Lounge at Indore last year. Interestingly, its ratio of food & beverages sales to room sales is 1.6 times as against industry norm of 0.7 times. The company further plans to add 77 rooms and 3 restaurants for which HUDCO has already agreed to finance. With a room base of over 200, Sayaji is expected to attract major national and international conferences and may clock a turnover of Rs.35 cr. and NP of Rs.6 cr. with an EPS of Rs.8 in FY06. A solid buy for the long-term.
In Textiles, investors can safely accumulate Seasons Textile (Code No: 514264) (Rs.17.50) as it has corrected substantially from its recent high of Rs.30 to the current Rs.18 levels. The company is engaged in the manufacture of furnishing fabrics on the latest automatic shuttleless loom and nearly 40% is exported. Last year on modernisation, it added new capacity of 2,40,000 mtrs in Noida plant whose full impact will be visible in the current fiscal. For the full year FY06, it may report an diluted EPS of Rs.4. Besides, the scrip has a strong support at Rs.15 as the company made preferential allotment of 15 lakh shares at Rs.15. With a book value of Rs.25 it’s a steal!

KIC Metallics(Code No:513693) (Rs.75) is into manufactures Pig iron, castings and slag cement. Recently, it set up a 1,44,000 TPA captive coke oven plant and is putting up a hot stove and 4 MW captive power plant. With all these developments, its input cost will come down substantially. Further, it plans to put 1,50,000 TPA steel billet plant and 1,00,00 TPA sponge iron plant besides increasing its pig iron capacity to 1,50,000 tonnes. Its June’05 qtr numbers were not so good as the MBF plant was shut down for nearly a month for relining. For FY06, it can report Sales of Rs.180 cr. and NP of Rs.10 cr. To fund its expansion the company is taking term loans and may raise capital from the market, which will dilute its equity. Yet, it’s a good bet at current levels and can give 30~50% return in a year.

Although there are talks of further fall in steel prices in the international market, SAIL (Code No: 500113) (Rs.57.50) is a reasonably good bet in this sector. Interestingly, this market leader which used to report heavy losses till a few years back is virtually debt free company today. It has chalked out huge expansion plans with a capex of Rs.35,000 cr. to maintain its leadership position for another 10 years. For FY05 its Sales jumped 33% Rs.29234 cr. and NP increased by 170% to Rs.6816 cr. registering an EPS of whopping Rs.17 and on which the company declared 33% dividend. For FY06, it can report an EPS of Rs.12~13 and may declare 25% dividend which works out to a dividend yield of more than 4%. Besides, the scrip has the potential to appreciate 50% in 9~12 months.
Haldyn Glass Gujarat Ltd.(Code No:515147) (Rs.67.85) is manufactures glass bottles/glass containers which are supplied to the beverages, beer, liquor, soft drinks and processed food industries. Last year, it successfully installed a captive power plant which has reduced the cost of production substantially. Recently, the company obtained the ISO 9001:2000 Standard Certification and is currently implementing the Enterprise Resource Planning (ERP) System to support its core process. For FY06 it can clock a turnover of Rs.60 cr. and NP of Rs.7.50 cr. which can lead to an EPS of Rs.14 on its current equity of Rs.5.40 cr. Investors can buy at CMP with a price target of Rs.120 in 9~12 months.

Friday, October 7, 2005

Shrachi Securities - Rs.47.00

Incorporated in 1989, Shrachi Securities Ltd (SSL) is the flagship financial services company of the Shrachi Group, which has diversified interest in Real Estate, Engineering, IT, Hospital, Packaging, Alcohol etc. SSL offers a wide range of financial products and services from financing passenger cars and light commercial vehicles to heavy commercial vehicles and construction equipment. Earlier, the company was known as Shrachi Infrastructure Finance and only recently acquired its current name. Today, SSL has emerged among the 10 biggest commercial vehicle financing companies in India. The company operates through 57 branches covering 12 major states and has a consortium of 12 banks led by Bank of Baroda.

SSL does not just finance in its own right; it finances commercial vehicles and construction equipment jointly with Citicorp and HDFC Bank leveraging their brand equity. Interestingly today SSL is the largest alliance member for HDFC and second largest for Citicorp on a national basis. Its main income is earned in the form of origination fees and collection charges (linked to collection efficiency) since interest spreads are typically low with yields on these assets relatively low compared to SSL’s own cost of funds. The fee based earning nature of this business is a positive as it partially insulates SSL from the yield volatility prevalent in commercial vehicle financing market. In short, it’s a professionally well-managed company with NPA level of around 1.50% only against the industry average of more than 5%. SSL also has a 100% subsidiary, Shrachi Auto Pvt. Ltd., which has the dealership of Ashok Leyland vehicles in Jharkhand and Bajaj Tempo in Ranchi, the capital of Jharkhand

For FY05, SSL’s disbursement grew to Rs.540 cr. against Rs.303 cr. in FY04 registering growth of 79%. Its capital adequacy stood at above 20% compared to the minimum 12% required by RBI. Its total income grew by 30% to Rs.25.40 cr. whereas its NP zoomed 140% to Rs.7.20 cr. posting an EPS of Rs.8.50 on its current equity of Rs.8.50 cr. and it declared a dividend of 15% for FY05. Due to the increasing importance of infrastructure financing, the company has proposes to expand its infrastructure funding operations for which it is planning to raise capital through preferential allotment and other means like FFCB, ADR etc, which will dilute its equity substantially in future. For FY06, the company may report a total revenue of Rs.35 cr. and NP of Rs.8.50 cr. Aggressive investors can accumulate this scrip with a price target of Rs.75 (65% return) in 12~15 months.

Thursday, October 6, 2005

Winsome Textiles - Rs.25.75

Incorporated in 1980, Winsome Textile Industries Ltd (WTIL) is a part of the well diversified Winsome Group, which has a strong foothold in textiles through its group companies like Winsome Spinners, Winsome Yarns, Winsome Spectrum, Winsome Knitwear etc. WTIL manufactures 100% raw cotton white yarn in the count range of NE 10s to NE 40s both carded and combed, single and folded. It also produces the finest quality melange yarn in 100 per cent cotton as well as cotton blends with viscose, polyester, acrylic, linen, modal, wool and silk which are used to make high value woven garments. Today, Winsome is the largest producer of melange yarn in India. It exports to more than 20 countries in the Far East, Europe, USA etc. and nearly 50% of its total turnover is accounted by exports.
WTIL’s spinning unit is located at Baddi in Himachal Pradesh with a capacity of 25,000 spindles while the group can boast of an installed capacity of more than 1,00,000 spindles with 9,500 kg per day yarn/fibre dyeing unit. It is an ISO9001-2000 certified company alongwith ISO14001 Environmental Management System Certificate issued by the Bureau of Indian Standards. Last year in March 2004, WTIL completed a modernization project leading to an increase in its combing capacity, replacement of 11 Ring Frames and other equipments without any cost overrun and as per TUFS guidelines. For future growth the company is implementing Rs.10.50 cr. capex plan to add 5 combers to convert part production of carded cotton yarn to combed yarn, which offer higher contributions. Also, some balancing machines are being planned for the Dyeing House to increase production. Notably, this whole exercise will be financed by debt and internal accrual without any equity dilution. The group is also planning to foray into manufacture & export of knitwear garments in a big way.

For FY05, its sales grew by 15% to Rs.128 cr. whereas its PBT was Rs.58 lakh compared to Rs.7 lakh last year. It managed these figures in spite of the fact that the company’s first half of FY05 was affected due to higher cotton prices and low yarn prices. However the current first qtr. numbers are quite encouraging. Although sales revenue flat at Rs.31 cr. the NP spurted 150% to Rs.1.08 cr. leading to an EPS of Rs.1.80 for the June’05 qtr. Given its small equity of just Rs.5.9 cr. and reserves of Rs.21.4 cr., the book value of the share works out to Rs.46. The value of its gross block as on 31st March 2005 stood at whopping Rs.119 cr. It also has investments whose current market value is more than Rs.10 cr. In spite of such strong fundamentals, the company’s current market cap is merely Rs.15~16 cr. For FY06, it is expected to report Sales of Rs.150 cr. and NP of Rs.4 cr. i.e. an EPS of around Rs.7. Investors are strongly recommended to buy this scrip with a price target of Rs.50 (i.e. 100% appreciation) in 9~12 months.